메뉴 건너뛰기




Volumn 225, Issue 2, 2012, Pages 135-140

Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor

Author keywords

Acneiform eruption; Epidermal growth factor; Epidermal growth factor receptor inhibitors

Indexed keywords

AFATINIB; BEVACIZUMAB; CARBOPLATIN; EASYEF; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; PACLITAXEL; RECOMBINANT EPIDERMAL GROWTH FACTOR; UNCLASSIFIED DRUG;

EID: 84870829158     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000342203     Document Type: Article
Times cited : (17)

References (25)
  • 1
    • 0036142522 scopus 로고    scopus 로고
    • Follicular toxic effects of chimeric anti-epidermal growth factor receptor antibody cetuximab used to treat human solid tumors
    • Kimyai-Asadi A, Jih MH: Follicular toxic effects of chimeric anti-epidermal growth factor receptor antibody cetuximab used to treat human solid tumors. Arch Dermatol 2002; 138: 129-131.
    • (2002) Arch Dermatol , vol.138 , pp. 129-131
    • Kimyai-Asadi, A.1    Jih, M.H.2
  • 2
    • 84864872002 scopus 로고    scopus 로고
    • Azithromycin pulses for the treatment of epidermal growth factor receptor inhibitorrelated papulopustular eruption: An effective and convenient alternative to tetracyclines
    • Nikolaou V, Strimpakos AS, Stratigos A, Katsambas A, Antoniou C, Syrigos KN: Azithromycin pulses for the treatment of epidermal growth factor receptor inhibitorrelated papulopustular eruption: an effective and convenient alternative to tetracyclines. Dermatology 2012; 224: 315-319.
    • (2012) Dermatology , vol.224 , pp. 315-319
    • Nikolaou, V.1    Strimpakos, A.S.2    Stratigos, A.3    Katsambas, A.4    Antoniou, C.5    Syrigos, K.N.6
  • 3
    • 33847012963 scopus 로고    scopus 로고
    • Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy
    • DeWitt CA, Siroy AE, Stone SP: Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. J Am Acad Dermatol 2007; 56: 500-505.
    • (2007) J Am Acad Dermatol , vol.56 , pp. 500-505
    • Dewitt, C.A.1    Siroy, A.E.2    Stone, S.P.3
  • 4
    • 35548969264 scopus 로고    scopus 로고
    • Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: An evolving paradigm in clinical management
    • Lynch TJ Jr, Kim ES, Eaby B, Garey J, West DP, Lacouture ME: Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist 2007; 12: 610-621.
    • (2007) Oncologist , vol.12 , pp. 610-621
    • Lynch Jr., T.J.1    Kim, E.S.2    Eaby, B.3    Garey, J.4    West, D.P.5    Lacouture, M.E.6
  • 5
    • 77951879709 scopus 로고    scopus 로고
    • Pimecrolimus cream 1% for the treatment of papulopustular eruption related to epidermal growth factor receptor inhibitors: A case series and a literature review of therapeutic approaches
    • Nikolaou V, Stratigos A, Antoniou C, et al: Pimecrolimus cream 1% for the treatment of papulopustular eruption related to epidermal growth factor receptor inhibitors: a case series and a literature review of therapeutic approaches. Dermatology 2010; 220: 243-248.
    • (2010) Dermatology , vol.220 , pp. 243-248
    • Nikolaou, V.1    Stratigos, A.2    Antoniou, C.3
  • 6
    • 0033757709 scopus 로고    scopus 로고
    • Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy
    • suppl 1)
    • Raymond E, Faivre S, Armand JP: Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs 2000; 60(suppl 1):15-23.
    • (2000) Drugs , vol.60 , pp. 15-23
    • Raymond, E.1    Faivre, S.2    Armand, J.P.3
  • 7
    • 0028955388 scopus 로고
    • Epidermal growth factor-related peptides and their receptors in human malignancies
    • Salomon DS, Brandt R, Ciardiello F, Normanno N: Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995; 19: 183-232.
    • (1995) Crit Rev Oncol Hematol , vol.19 , pp. 183-232
    • Salomon, D.S.1    Brandt, R.2    Ciardiello, F.3    Normanno, N.4
  • 8
    • 0033063774 scopus 로고    scopus 로고
    • The epidermal growth factor receptor and its inhibition in cancer therapy
    • Woodburn JR: The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 1999; 82: 241-250.
    • (1999) Pharmacol Ther , vol.82 , pp. 241-250
    • Woodburn, J.R.1
  • 9
    • 3242720345 scopus 로고    scopus 로고
    • Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
    • Cunningham D, Humblet Y, Siena S, et al: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351: 337-345.
    • (2004) N Engl J Med , vol.351 , pp. 337-345
    • Cunningham, D.1    Humblet, Y.2    Siena, S.3
  • 10
    • 2142641698 scopus 로고    scopus 로고
    • Phase ii trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor
    • Saltz LB, Meropol NJ, Loehrer PJ Sr, Needle MN, Kopit J, Mayer RJ: Phase ii trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 2004; 22: 1201-1208.
    • (2004) J Clin Oncol , vol.22 , pp. 1201-1208
    • Saltz, L.B.1    Meropol, N.J.2    Loehrer Sr., P.J.3    Needle, M.N.4    Kopit, J.5    Mayer, R.J.6
  • 11
    • 38549088386 scopus 로고    scopus 로고
    • Dermatologic toxicities associated with EGFR inhibitors: The clinical psychologist's perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae
    • Wagner LI, Lacouture ME: Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist's perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae. Oncology (Williston Park) 2007; 21(11 suppl 5): 34-36.
    • (2007) Oncology (Williston Park) , vol.21 , Issue.11 SUPPL. 5 , pp. 34-36
    • Wagner, L.I.1    Lacouture, M.E.2
  • 12
    • 34249933404 scopus 로고    scopus 로고
    • Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase iii trial of the national cancer institute of Canada clinical trials group
    • Moore MJ, Goldstein D, Hamm J, et al: Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase iii trial of the national cancer institute of Canada clinical trials group. J Clin Oncol 2007; 25: 1960-1966.
    • (2007) J Clin Oncol , vol.25 , pp. 1960-1966
    • Moore, M.J.1    Goldstein, D.2    Hamm, J.3
  • 13
    • 22044445517 scopus 로고    scopus 로고
    • Erlotinib in previously treated nonsmall-cell lung cancer
    • Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al: Erlotinib in previously treated nonsmall-cell lung cancer. N Engl J Med 2005; 353: 123-132.
    • (2005) N Engl J Med , vol.353 , pp. 123-132
    • Shepherd, F.A.1    Rodrigues Pereira, J.2    Ciuleanu, T.3
  • 14
    • 1542713370 scopus 로고    scopus 로고
    • Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT 2
    • Herbst RS, Giaccone G, Schiller JH, et al: Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial-INTACT 2. J Clin Oncol 2004; 22: 785-794.
    • (2004) J Clin Oncol , vol.22 , pp. 785-794
    • Herbst, R.S.1    Giaccone, G.2    Schiller, J.H.3
  • 15
    • 76649083897 scopus 로고    scopus 로고
    • Lenalidomide-induced acute acneiform folliculitis of the head and neck: Not only the anti-EGF receptor agents
    • Michot C, Guillot B, Dereure O: Lenalidomide-induced acute acneiform folliculitis of the head and neck: not only the anti-EGF receptor agents. Dermatology 2010; 220: 49-50.
    • (2010) Dermatology , vol.220 , pp. 49-50
    • Michot, C.1    Guillot, B.2    Dereure, O.3
  • 16
    • 27844440990 scopus 로고    scopus 로고
    • Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia
    • Gambillara E, Laffitte E, Widmer N, et al: Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia. Dermatology 2005; 211: 363-365.
    • (2005) Dermatology , vol.211 , pp. 363-365
    • Gambillara, E.1    Laffitte, E.2    Widmer, N.3
  • 18
    • 0036139727 scopus 로고    scopus 로고
    • Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition
    • Albanell J, Rojo F, Averbuch S, et al: Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition. J Clin Oncol 2002; 20: 110-124.
    • (2002) J Clin Oncol , vol.20 , pp. 110-124
    • Albanell, J.1    Rojo, F.2    Averbuch, S.3
  • 19
    • 0035724536 scopus 로고    scopus 로고
    • Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225
    • Busam KJ, Capodieci P, Motzer R, Kiehn T, Phelan D, Halpern AC: Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol 2001; 144: 1169-1176.
    • (2001) Br J Dermatol , vol.144 , pp. 1169-1176
    • Busam, K.J.1    Capodieci, P.2    Motzer, R.3    Kiehn, T.4    Phelan, D.5    Halpern, A.C.6
  • 20
    • 12444259660 scopus 로고    scopus 로고
    • Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients
    • Malik SN, Siu LL, Rowinsky EK, et al: Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients. Clin Cancer Res 2003; 9: 2478-2486.
    • (2003) Clin Cancer Res , vol.9 , pp. 2478-2486
    • Malik, S.N.1    Siu, L.L.2    Rowinsky, E.K.3
  • 21
    • 0028179669 scopus 로고
    • P27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
    • Polyak K, Kato JY, Solomon MJ, et al: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-22.
    • (1994) Genes Dev , vol.8 , pp. 9-22
    • Polyak, K.1    Kato, J.Y.2    Solomon, M.J.3
  • 22
    • 63249120652 scopus 로고    scopus 로고
    • Malassezia folliculitis presented as acneiform eruption after cetuximab administration
    • Cholongitas E, Pipili C, Ioannidou D: Malassezia folliculitis presented as acneiform eruption after cetuximab administration. J Drugs Dermatol 2009; 8: 274-275.
    • (2009) J Drugs Dermatol , vol.8 , pp. 274-275
    • Cholongitas, E.1    Pipili, C.2    Ioannidou, D.3
  • 23
    • 79955692259 scopus 로고    scopus 로고
    • Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitors
    • Gerber PA, Kukova G, Buhren BA, Homey B: Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitors. Dermatology 2011; 222: 144-147.
    • (2011) Dermatology , vol.222 , pp. 144-147
    • Gerber, P.A.1    Kukova, G.2    Buhren, B.A.3    Homey, B.4
  • 24
    • 41449095523 scopus 로고    scopus 로고
    • Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: Results of an experts panel meeting
    • Gridelli C, Maione P, Amoroso D, et al: Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an experts panel meeting. Crit Rev Oncol Hematol 2008; 66: 155-162.
    • (2008) Crit Rev Oncol Hematol , vol.66 , pp. 155-162
    • Gridelli, C.1    Maione, P.2    Amoroso, D.3
  • 25
    • 37349121157 scopus 로고    scopus 로고
    • Erlotinib-induced florid acneiform rash complicated by extensive impetiginization
    • Kardaun SH, van Duinen KF: Erlotinib-induced florid acneiform rash complicated by extensive impetiginization. Clin Exp Dermatol 2008; 33: 46-49.
    • (2008) Clin Exp Dermatol , vol.33 , pp. 46-49
    • Kardaun, S.H.1    Van Duinen, K.F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.